Stay updated on Sublingual Dexmedetomidine in Schizophrenia-Associated Agitation Clinical Trial

Sign up to get notified when there's something new on the Sublingual Dexmedetomidine in Schizophrenia-Associated Agitation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sublingual Dexmedetomidine in Schizophrenia-Associated Agitation Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    A consolidated Locations section has been added listing study sites across multiple states (Arkansas, California, Florida, Georgia, Maryland, Mississippi, New Jersey, Texas). The previous per-state location subsections have been removed.
    Difference
    1.0%
    Check dated 2025-12-23T17:13:03.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and v3.2.0 was removed on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T21:15:37.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The government funding notice banner was removed from the page; no changes to study content or eligibility details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T18:37:51.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The update appears to be minor UI tweaks with no addition or removal of core study content (title, conditions, interventions, primary outcomes, locations, or sponsor). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:10:40.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Added a government-operating-status notice and updated version to v3.2.0; removed v3.1.0.
    Difference
    4%
    Check dated 2025-10-05T22:47:25.000Z thumbnail image
  9. Check
    99 days ago
    Change Detected
    Summary
    Updated to Revision v3.1.0 and removed several specific drug-related topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the prior version.
    Difference
    0.4%
    Check dated 2025-09-28T19:28:09.000Z thumbnail image

Stay in the know with updates to Sublingual Dexmedetomidine in Schizophrenia-Associated Agitation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sublingual Dexmedetomidine in Schizophrenia-Associated Agitation Clinical Trial page.